Overview

Jim has defended clients in complex litigation for more than three decades, serving as national counsel, first- and second-chair trial counsel, work-up counsel, and in a variety of additional roles. He is skilled in managing fact and expert depositions, expert development and Rule 702 strategy. Jim’s clients have included some of the world’s largest multinational companies in the health and life sciences sector, technology enterprises, food and confectionary businesses, as well as individuals. As a former assistant U.S. attorney, Jim leverages his experience — particularly trial experience — to provide clients comprehensive advice and representation in sophisticated product liability matters.

Jim is also the co-chair of the health and life sciences segment of Faegre Drinker’s artificial intelligence and automated decision-making (AI-X) team, an interdisciplinary group of attorneys, consultants and in-house data scientists who:

  • advise clients on emerging laws, regulations and industry standards relating to AI technologies
  • help clients develop responsible AI governance models
  • counsel on regulatory compliance, best practices, risk management and risk allocation related to these technologies
  • help clients to leverage, license and protect proprietary data and models
  • provide effective advocacy when litigation involving these technologies arises

The AI-X team’s health and life sciences segment brings this holistic approach and deep industry understanding to assist clients on issues related to artificial intelligence, machine learning, Big Data and automated decision-making. These technologies are transforming health care, and the AI-X team helps clients innovate in this space, wherever they are in their journey.

Product Liability & Mass Torts

Since entering private practice, Jim has focused on the defense of health and life sciences companies — particularly pharmaceutical and medical device manufacturers — in product liability litigation. He has represented clients in single-plaintiff actions, mass actions and MDLs. Covering a range of pharmaceutical products and medical devices, Jim’s experience includes blood products and factor concentrates, diet drugs, hormone therapy, antibiotics, anticoagulants, and a variety of orthopedic medical devices.

In addition, Jim represents food and confectionary companies in product liability litigation, including consumer fraud and consumer class actions in state and federal courts.

Consistent with his concentration in technology / artificial intelligence, Jim also defends technology companies in personal injury and product liability cases around the country.

Additional Litigation Experience

  • A decade defending individual health care providers and institutions in professional liability matters including all aspects of litigation such as discovery, trial and appeal.
  • The defense of residential property owners in toxic tort cases alleging childhood brain injury from exposure to lead-based paint.
  • Prosecuting complex antitrust suits involving claims challenging pharmaceutical contracting practices.
  • Defense of an international charitable foundation against claims related to human medical experiments conducted in Central America in the 1940s.

Personal Interests

An avid cyclist and triathlete, Jim also enjoys rock climbing and exploring the outdoors with his wife and three adult children.

Related Topics

Credentials

Bar Admissions

Maryland
District of Columbia

Court Admissions

U.S. Supreme Court
U.S. Court of Appeals for the Third Circuit
U.S. Court of Appeals for the Fourth Circuit
U.S. District Court for the District of Columbia
U.S. District Court for the District of Maryland
U.S. District Court for the District of Colorado

Education

Lehigh University
B.S. in Business and Economics Law (1989)

The Dickinson School of Law of Pennsylvania State University
J.D. Journal of International Law (editor) (1992)

Insights & Events

Latest
最新 January 2025

FDA Issues Detailed Guidance for Biopharma Industry on What Information to Provide to FDA About Use of AI Models

A Seven-Step Process and Detailed Recommendations for Submissions
6 min read  
最新 January 2025

FDA Makes Draft Guidance Available on Lifecycle Management and Marketing Submission Recommendations for AI-Enabled Device Software Functions and Requests Industry Input

6 min read  
Recorded Webinar December 04, 2024

One Year After Biden’s AI Executive Order: AI Compliance Programs & What Health & Life Sciences Companies Should Know - Webinar

1 min read  
Blog Post November 2024

New EU Product Liability Directive Published in Official Journal

Faegre Drinker on Products blog
1 min read  
最新 September 2024

Biopharma & Medical Devices Briefing: LLMs in Health Care; Nitrosamine in Pharma; PFAS; and CDER’s Quantitative Medicine Center of Excellence

5 min read  
最新 September 2024

Recap of the FDA and CTTI Public Workshop on AI in Drug Development

3 min read  
Recorded Webinar June 12, 2024 CLE

AI in Global Health Care: Cross-Border Governance Strategies and Insights - Webinar

International Business Briefing
2 min read  
Speaking Engagement Recap April 04, 2024

Life in the Gray Area - Product Liability Issues Surrounding Artificial Intelligence

PLAC Spring Conference 2024
1 min read  
News August 2022

215 Faegre Drinker Attorneys Recognized in Best Lawyers in America 2023 Edition

14 min read  
News August 2021

174 Faegre Drinker Attorneys Recognized in Best Lawyers in America 2022 Edition

12 min read  
Insights
最新 January 2025

FDA Issues Detailed Guidance for Biopharma Industry on What Information to Provide to FDA About Use of AI Models

A Seven-Step Process and Detailed Recommendations for Submissions
6 min read  
最新 January 2025

FDA Makes Draft Guidance Available on Lifecycle Management and Marketing Submission Recommendations for AI-Enabled Device Software Functions and Requests Industry Input

6 min read  
Blog Post November 2024

New EU Product Liability Directive Published in Official Journal

Faegre Drinker on Products blog
1 min read  
最新 September 2024

Biopharma & Medical Devices Briefing: LLMs in Health Care; Nitrosamine in Pharma; PFAS; and CDER’s Quantitative Medicine Center of Excellence

5 min read  
最新 September 2024

Recap of the FDA and CTTI Public Workshop on AI in Drug Development

3 min read  
最新 September 2024

Artificial Intelligence Briefing: Lawsuits, Agreements and Comments – Oh My!

7 min read  
最新 July 2024

Artificial Intelligence Briefing: White House Announces the Completion of Agency Actions Required by the AI Executive Order

12 min read  
最新 July 2024

NIST Makes Good on Biden’s Executive Order on AI, Delivering Algorithm-Testing Software and Multiple AI-Related Guidance Documents to the Public

4 min read  
发表文章 June 2024

Product Liability Laws and Regulations USA 2024

International Comparative Legal Guides
1 min read  
媒体报道 May 2024

Jim Frederick and Hannah Anderson Lay Out Potential AI Legislation For Fierce Healthcare

2 min read  
Other Perspectives

Firm Blog Contributions

  • Faegre Drinker on Products – a blog addressing all things product liability that covers legal issues and developments of interest to product manufacturers and their employers

Leadership & Community

Professional Associations

  • PLAC (formerly known as the Products Liability Advisory Council) — HLTh (Health & Life Sciences Technology) Working Group, Founding Co-chair
  • International Association of Defense Counsel
  • Defense Research Institute — Drug and Medical Device Committee; Long Range Planning Committee (standing committee) 2016-17
  • Federal Bar Association, Maryland Chapter
  • Maryland Defense Counsel
  • Maryland State Bar Association
  • Wednesday Law Club — Vice-President, 2023-present; Secretary/Treasurer, 2020-23

Honors

  • Best Lawyers® — Commercial Litigation, 2022-23
  • Faegre Drinker — Pro Bono Honor Roll, 2023
  • Who’s Who Legal: Life Sciences — Product Liability, 2017
  • Martindale-Hubbell — Peer Review Rating: AV® Preeminent